Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study

A Lavy1, E Broide, S Reif

  • 1Department of Gastroenterology, Asaf Center, Isreal. lavya@netvision.net.il

Insights

Childhood measles exposure may increase Crohn's disease risk. This study found higher measles exposure and IgG antibodies in Crohn's patients, suggesting a potential role for measles infection in disease development.

Area of Science:

  • Gastroenterology
  • Virology
  • Epidemiology

Background:

  • The cause of Crohn's disease (CD) is unknown, with a transmissible agent being a long-standing hypothesis.
  • Measles virus has been investigated for its potential role in inflammatory bowel disease (IBD) pathogenesis.
  • The link between early measles infection and later CD development remains unclear.

Purpose of the Study:

  • To investigate the potential association between measles virus infection and the development of Crohn's disease.
  • To compare measles exposure and serological markers between CD patients, ulcerative colitis (UC) patients, and control groups.

Main Methods:

  • A large-scale, multicenter study involving 531 IBD patients (260 CD, 271 UC) and 903 matched controls (clinical and community).
  • Interviews were conducted to assess patient history, including measles vaccination and childhood exposure.
  • Blood samples from 104 IBD patients and 50 controls were analyzed for measles virus IgG antibodies.

Main Results:

  • No significant differences in measles vaccination rates were observed between CD, UC, and control groups.
  • Childhood exposure to measles was significantly more frequent in CD patients compared to community controls (p < 0.05).
  • CD patients showed a trend towards higher IgG antibodies to measles virus compared to UC patients and controls (p = 0.084).
  • CD patients with a history of childhood measles were more likely to have large bowel disease.

Conclusions:

  • The findings suggest a potential role for measles infection in the pathogenesis of Crohn's disease.
  • Further research is warranted to elucidate the precise mechanism by which measles infection may influence CD development.
  • While not definitive, the data support continued investigation into infectious agents as triggers for Crohn's disease.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...